Kidney and Ureteric Stones: China's 2025 Urolithiasis Guideline
Stones come back in more than half of patients within five years. The 2025 Chinese guideline pairs modern minimally invasive treatment with a genuinely detailed metabolic workup and prevention plan.
Urinary stone disease affects roughly 6 to 10 percent of people in China, with rates above 15 percent in parts of the south. It is a disease of recurrence: after a first stone, the five-year recurrence rate is 35 to 50 percent and the ten-year figure is above 70 percent. China's 2025 urolithiasis guideline, produced by the Chinese Urological Association together with the national urolithiasis alliance and graded with GRADE, treats prevention as seriously as removal.
Who gets stones
How they present
Diagnosis
Metabolic evaluation
Stone composition analysis - infrared spectroscopy being the most accurate - should be performed on any stone that is passed or removed, because composition drives prevention.
